Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021

SELL
$43.41 - $56.51 $2.77 Million - $3.6 Million
-63,735 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$47.43 - $60.75 $471,833 - $604,341
9,948 Added 18.5%
63,735 $3.1 Million
Q2 2020

Aug 14, 2020

BUY
$43.51 - $66.59 $51,776 - $79,242
1,190 Added 2.26%
53,787 $2.99 Million
Q1 2020

May 14, 2020

BUY
$32.82 - $81.13 $254,847 - $629,974
7,765 Added 17.32%
52,597 $2.66 Million
Q4 2019

Feb 11, 2020

SELL
$60.96 - $77.7 $189,585 - $241,647
-3,110 Reduced 6.49%
44,832 $3.47 Million
Q3 2019

Nov 12, 2019

BUY
$55.78 - $68.08 $17,180 - $20,968
308 Added 0.65%
47,942 $3.04 Million
Q2 2019

Aug 14, 2019

SELL
$53.69 - $65.47 $819,738 - $999,595
-15,268 Reduced 24.27%
47,634 $0
Q1 2019

May 15, 2019

SELL
$44.53 - $58.9 $1.05 Million - $1.39 Million
-23,515 Reduced 27.21%
62,902 $0
Q4 2018

Feb 15, 2019

BUY
$47.64 - $71.26 $4.12 Million - $6.16 Million
86,417 New
86,417 $4.28 Million

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Segall Bryant & Hamill, LLC Portfolio

Follow Segall Bryant & Hamill, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.